Sheng Cui, Ph.D. 
Chief Manufacturing Officer
NewAmsterdam Pharma 

Sheng Cui, Ph.D., is the Chief Manufacturing Officer at NewAmsterdam Pharma (NAP), where he oversees process development, manufacturing and supply. Prior to joining NAP in 2021, he  spent two years at Boston Pharmaceuticals as Vice President of CMC, where he managed phase-appropriate development strategy and execution for a diversified portfolio, and also served 12 years in Amgen, where he took on roles of increasing leadership responsibility for advancing synthetic drug candidates that spanned the life cycle from preclinical to commercialization on numerous development candidates and commercial products.